We invite you to view a free webinar recording describing how primary care providers – particularly those working in public and community health centers – can lead the US effort to eliminate tuberculosis by implementing a comprehensive, risk-based TB screening program. You'll learn more about the most recent recommendations on TB testing and how IGRA-based screening programs can support TB elimination efforts while increasing efficiencies at the practice level.
QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to- date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.